Patent ID: 8012971
Filing Date: 2011-09-06
Classification: A61K,A61P,C07D

Abstract:
1. A crystalline form of N-{2-[2-[(3-Fluorophenyl)imino]-4-(4-morpholin-4-ylphenyl)-1,3-thiazol-3(2H)-yl]ethyl}-N′-methylurea of the formula (2): having a needle form showing at least one property selected from: a) a powder X-ray crystallography having peaks are on 2θ of 5.8, 11.5, 13.3, 16.7, 18,7, 19.0, 20.3, 22.1, 24.1, 24.5, and 26.0; and b) an infrared absorption spectrum having characteristic absorption bands at 3328, 2949, 2852, 1618, 1595, and 1577 cm